Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 18, 2025 08:00 ET | Source: Nutriband Inc.

Nutriband Inc. Signs Letter of Intent with Qvanta Group of Companies to Explore Advanced Technology Solutions for Abuse-Deterrent Pharmaceutical Innovation Strategic Exploration

Quanta LOI
December 17, 2025 13:30 ET | Source: BioNTX

BioNTX Celebrates 2025 Rising Stars Driving North Texas’ Life Science Innovation

Plano, Texas, Dec. 17, 2025 (GLOBE NEWSWIRE) -- As 2025 comes to a close, BioNTX reflects on a year of innovation, growth, and achievement across North Texas’ life science ecosystem, highlighted by...
December 17, 2025 04:00 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics Management to Attend Partnering Meetings During JPM Week, January in San Francisco, California

VANCOUVER, British Columbia, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative...
December 16, 2025 16:05 ET | Source: TheRas, Inc. (d/b/a BBOT)

BBOT to Present at the 44th Annual J.P. Morgan Healthcare Conference

BBOT today announced that members of its leadership team will participate in a presentation at the 44th Annual J.P. Morgan Healthcare Conference.
December 16, 2025 12:18 ET | Source: Equity Insider

Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary – The FDA is moving to require just one clinical trial for new drug approvals, signaling a dramatic...
December 16, 2025 12:00 ET | Source: USA News Group

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in mice using a combined blood stem cell and...
December 16, 2025 08:40 ET | Source: Silexion Therapeutics Corp

Silexion Therapeutics Announces Submission of Phase 2/3 Clinical Trial Application to Israel for SIL204 in Locally Advanced Pancreatic Cancer

Regulatory submission marks a significant milestone as the Company advances toward Phase 2/3 trial initiation in Q2 2026 at full speed Application follows recent successful toxicology studies,...
December 16, 2025 07:30 ET | Source: Vertero Therapeutics, Inc.

Vertero Strengthens Board of Directors with Appointment of Independent Chair R. Scott Greer

Vertero strengthens Board of Directors with Independent Chair R. Scott Greer, life sciences veteran, experienced executive, investor, and advisor.
December 16, 2025 06:30 ET | Source: Beacon Biosignals

Beacon Biosignals Announces Partnership with Harmony Biosciences to Advance Objective Clinical Endpoints in Hypersomnia Conditions Through Quantitative EEG

Beacon Biosignals partners with Harmony Biosciences to quantitatively measure excessive daytime sleepiness in phase 3 clinical trial.
December 16, 2025 06:00 ET | Source: Culture Biosciences

Culture Biosciences Announces Close of Series C Round to Accelerate Commercial Growth of Stratyx 250 and Console Platform

Culture Biosciences closed a Series C to scale Stratyx™ 250 and advance its AI-powered Console platform for biologics, cell therapy, and synthetic biology.